Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Dig Dis Sci. 2019 Aug 1;65(1):111–118. doi: 10.1007/s10620-019-05754-9

Table 3:

Comparison of index colonoscopy and non-inflammatory bowel disease risk factors for interval colorectal cancer in patients with and without inflammatory bowel disease

IBD Non-IBD P
Female, n (%) 4 (26.7) 103 (44.6) 0.18

Age at index colonoscopy, mean (SD) 52.8 (15.6) 67.5 (11.7) <0.0001

Age of CRC diagnosis, mean (SD) 54.5 (15.7) 70.4 (11.8) <0.0001

Time from index colonoscopy to cancer diagnosis (months), mean (SD) 20.7 (14.1) 35.1 (16.1) 0.0009

Indication for index colonoscopy
  Screening, n (%) 10 (66.7) 67 (29.1) 0.002
  Surveillance, n (%) 3 (20.0) 103 (44.8) 0.06
  Diagnostic, n (%) 2 (13.3) 60 (26.1) 0.27

Cecum intubated, n (%) 14 (93.3) 210 (92.1) 0.86
Adequate prep, n (%) 10 (76.9) 154 (75.1) 0.88

Personal History of CRC, n (%) 2 (13.3) 38 (16.5) 0.75

HNPCC or FAP1, n (%) 0 (0.0) 7 (3.0) 0.49

Family history CRC, n (%) 2 (13.3) 23 (10.0) 0.67
1

HNPCC = Hereditary nonpolyposis colorectal cancer, FAP = Familial Adenomatous Polyposis